While companies like DeepSeek may find success in certain market segments, they face an uphill battle against this massive ...

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...

Shares of Pfizer Inc. PFE shed 1.45% to $26.52 Friday, on what proved to be an all-around grim trading session for the stock ...

The company's revenue from operations dipped 0.4% to ₹538 crore as against ₹540 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA fell ...

The work underway at the former Pfizer headquarters marks a significant addition to Gensler’s office-to-residential conversion portfolio. Its first foray into the typology was at Pearl House in the ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

The former President of Pfizer Global Manufacturing gifted $50 million to his former school, Northfield Mount Hermon.

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...